View Your Verification of Attendance Report
The American Optometric Association has a map available listing state requirements:
Find Your State Board CE Requirements and Affiliate Contacts
To use this map, use the drop down to select whether you want to search for your State Board or Affiliate. Then, simply click your state or national affiliate.
SECO education is accepted without other accreditation in the following states:
Alabama
Arizona
Connecticut
Georgia
Hawaii
Kentucky
Indiana
Iowa
Louisiana
Mississippi
Missouri
Montana
Nevada
New Hampshire
New Mexico
Oklahoma
Tennessee
Virginia
West Virginia
AFOS education is accepted without other accreditation in the following states:
Arizona
California
Connecticut
Delaware
Hawaii
Iowa
Kentucky
Montana
Nebraska
New Mexico
Oklahoma
Rhode Island
Virginia
Washington
As with the rest of the program, it is advisable that attendees verify their state board requirements before selecting courses to attend.
Credit Reporting
CE Broker
SECO will submit applicable courses to CE Broker for approval in SC, FL and/or FL.
Credit Reporting: SECO will submit attendance to CE Broker (SC, FL, TX) within 30 days following the activity if the appropriate CE Broker license number is correctly entered on the attendee registration form.
Transcript Quality/Continuing Education with Examination Courses (CEE/TQ)
Several courses at this event are designated as “CEE/TQ” for optometrists in states that require “Transcript Quality” continuing education for license renewal such as Florida and Illinois. Please check with your state’s Board of Optometry to confirm whether this applies to your license.
If you register for and complete a CEE/TQ-approved course, you’ll receive an email shortly after the event with a link to take the required online exam. The exam must be completed within 90 days of receiving the email. If you do not receive the email, please reach out to us at education@secostaff.com.
Credit Reporting: CE credit will be updated to CEE/TQ in FL CE Broker within two weeks of test completion.
IL OD Approved Provider
All live OD courses have been approved by the Illinois Board of Optometry. The Department recognizes that SECO International, LLC has complied with the provisions of the Illinois statutes and or rules and regulation and is hereby authorized to engage in the activity of: Licensed Optometry CE Sponsor, expiration date of March 31, 2026, license number 138.000093.
Credit Reporting: The attendee is responsible for reporting their attendance to the IL board on their behalf.
COPE
SECO also submits courses to COPE for the few states that require approval. This activity, COPE Activity Number 131277, is accredited by COPE for continuing education for optometrists.
Credit Reporting: SECO will submit to COPE/ARBO within 30 days following the activity if the appropriate OE Tracker number is correctly entered on the attendee registration form.
Standards for Commercial Support Compliance: Event Financial Support
The content of this COPE Accredited CE activity was planned and prepared independently by AFOS and SECO without input from members of a commercial interest.
Disclosure of Relevant Financial Relationships
The following individuals are in a position to control the content of this CE activity. Their relationships with commercial interests are disclosed below:
Name of Individual | Role in Activity | Nature of Commercial Interest | Nature of Relationship |
---|---|---|---|
Andriana Foster | Education Director | N/A | SECO Employee |
Renae Shepherd | Education Consultant | N/A | SECO Consultant |
Beth Weber | Education Manager | N/A | SECO Employee |
Walter Mayo, OD | SECO Technology Consultant | N/A | SECO Technology Consultant |
Christopher Wroten, OD | SECO Volunteer - Gen. CE Chair | Alcon | Consulting Fees |
Lindsay Wright, OD | AFOS Education Team | N/A | AFOS Volunteer |
None of the other individuals in a position to control the content of this activity — including planning committee members, instructors, or moderators/facilitators — have any relevant financial relationships with a COPE-defined commercial interest to disclose.